LXRX

Lexicon Pharmaceuticals, Inc.

2.24 USD
+0.12 (+5.66%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Lexicon Pharmaceuticals, Inc. stock is up 30.23% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52% of the previous 24 July’s closed higher than June. In the last 5 Unusual Options Trades, there were 5 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Jun 13:43 18 Oct, 2024 2.50 CALL 999 2780
20 Jun 17:35 18 Oct, 2024 2.00 CALL 2804 814
20 Jun 17:35 18 Oct, 2024 2.00 CALL 2499 814
20 Jun 17:35 18 Oct, 2024 2.00 CALL 2189 814
21 Jun 19:51 18 Oct, 2024 2.00 CALL 4183 11188

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the. treatment of neuropathic pain.

  • HC Wainwright & Co.
    Mon Jun 24, 06:31
    buy
    confirm
  • HC Wainwright & Co.
    Fri Jun 21, 10:12
    buy
    confirm
  • HC Wainwright & Co.
    Mon Jun 17, 06:18
    buy
    initial